Lumexa Imaging Opens Record 9 New Imaging Centers in 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2026
0mins
Source: Newsfilter
- Network Expansion: Lumexa Imaging set a record by opening nine new imaging centers in 2025, increasing its total to over 185 centers across 13 states, significantly enhancing the company's market coverage and service capabilities nationwide.
- Patient Service Enhancement: The new centers not only improve the patient experience for imaging exams but also make it easier for patients to complete MRIs, CTs, and PET/CTs through extended hours and convenient retail locations, thereby increasing accessibility to healthcare services.
- Strategic Growth: The Chief Growth Officer stated that Lumexa Imaging's de novo growth strategy focuses on high-growth metropolitan statistical areas, which is expected to continue driving business growth in 2026 and further solidify its position as the second-largest provider in the imaging services market.
- Future Outlook: With an aging population and rising chronic conditions, Lumexa Imaging plans to continue opening more new centers in collaboration with joint venture partners to meet the increasing healthcare demand, ensuring sustained value for both shareholders and patients.
Analyst Views on LMRI
Wall Street analysts forecast LMRI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMRI is 22.71 USD with a low forecast of 22.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 14.050
Low
22.00
Averages
22.71
High
23.00
Current: 14.050
Low
22.00
Averages
22.71
High
23.00
About LMRI
Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
